<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000410734"><TermName>Alimta</TermName><TermPronunciation>(uh-LIM-tuh)</TermPronunciation><TermDefinition><DefinitionText>A drug used alone or with another drug to treat certain types of non-small cell lung cancer and malignant pleural mesothelioma. It is being studied in the treatment of other types of cancer. Alimta blocks DNA synthesis and may kill cancer cells. It is a type of folate antagonist. Also called LY231514 and pemetrexed disodium.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000713118" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Alimta&quot;" language="en" id="_3"/><MediaLink ref="CDR0000713117" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Alimta&quot;" language="es" id="_4"/><SpanishTermName>Alimta</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa solo o con otro fármaco para tratar ciertos tipos de cáncer de pulmón de células pequeñas y mesotelioma pleural maligno. Está en estudio para el tratamiento de otros tipos de cáncer. Alimta bloquea la síntesis del ADN y puede destruir células cancerosas. Es un tipo de antagonista del folato. También se llama LY231514 y pemetrexed disódico.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2005-03-24</DateFirstPublished><DateLastModified>2009-04-24</DateLastModified><RelatedInformation><RelatedDrugSummaryRef href="CDR0000487511">Pemetrexed Disodium</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
